Today

Agents

Chat

Arena

Discover

More

App

PTC Therapeutics Q2 Net Income USD 83.496 Million - PTCT News | Rallies

PTC Therapeutics Q2 Net Income USD 83.496 Million

PTCT•2026-07-30

Quarterly results

Reuters reported that PTC Therapeutics said Q2 net income was USD 83.496 million.

Q2 operating expenses: USD 211.542 million
Q2 product revenue: USD 238,819,238.819 million
Q2 operating income: USD 148.977 million
Q2 basic EPS: USD 1.01
Outlook FY revenue: USD 1,180–1,280 million

Related News

Eastman 2Q FY26 adjusted EPS rises 23.13% to 1.97; revenue increases 10% to $2.51 billion

EMN•2026-07-30

Aqua Metals Q2 FY26 operating loss narrows to $4.59 million; net loss falls to $4.48 million

AQMS•2026-07-30

CooperCompanies updates financial calendar with Q3 results release, conference call schedule

COO•2026-07-30

MSA Safety Q2 sales beat analyst estimates

MSA•2026-07-30

Mettler-Toledo Q2 sales meet expectations on strength in China, emerging markets

MTD•2026-07-30